Showing results (4171-4180 of 5,590) with videos related to
Sort By:
Pageof 559
Theranostics|August 6, 2026
Quantitative MRI Pharmacokinetic Modeling and MALDI Mass Spectrometry Imaging Biodistribution of a pH Mapping MRI Contrast AgentZinia Mohanta, Caitlin M Tressler, Sadakatali Gori, et al.Theranostics|August 6, 2026
Metabolic-Immune Reprogramming via CuZnS@BSA Nanoregulators to Overcome Resistance in Triple-Negative Breast CancerJingyi Yang, Qi Li, Pi Zhao, et al.Theranostics|August 6, 2026
A mechanobiology-driven cell-derived ECM bioink for engineering 3D glioblastoma tumor microenvironment modelsSeohyeon An, Seoyul Jo, GeunHyung KimTheranostics|September 8, 2026
Nano-flow intracalvariosseous infusion enables skull-to-brain delivery of BBB-impermeable molecular and nanoscale agents in mice and rabbitsJi Hee Kang, O Hyun Lee, Min Suk Shim, et al.Theranostics|September 8, 2026
PEGylated IL2 and tumor-targeted radiotherapy augment CD8+ T cell-mediated anti-tumor response to anti-PD-1 in head and neck squamous cell carcinomaWon Jong Jin, Hari Menon, Amber Bates, et al.Theranostics|September 8, 2026
Colon-targeted oral delivery of melatonin for regulating macrophage activity and intestinal barrier in ulcerative colitisNhu-Nam Nguyen, Yoojin Seo, Tiep Tien Nguyen, et al.Theranostics|September 8, 2026
Novel nastorazepide-based radioligands demonstrate effective cholecystokinin-2 receptor targeting with potential for theranostic applicationsLennart Bohrmann, Doroteja Novak, Marko Kroselj, et al.Theranostics|September 8, 2026
3D vascular mapping reveals multi-organ injury following severe acute pancreatitisXiaomei Liu, Jingtan Zhu, Qiao Shi, et al.Theranostics|September 8, 2026
Engineered nanomedicine remodels the postoperative cavity microenvironment to suppress glioblastoma recurrenceZhiqun Bai, Zhiguang ChenTheranostics|September 8, 2026
Radiocopper in BCMA-targeted immunotheranostics of myelomaMartin Ullrich, Kristof Zarschler, Manja Kubeil, et al.Pageof 559